$ALRN News Article - Aileron Therapeutics Announces FDA Acceptance of IND for ALRN-6924 as a Myelopreservation Agent in Patients with p53-mutant Cancer Treated with Chemotherapy https://marketwirenews.com/news-releases/aile...23862.html
(0)
(0)
American Learning Corp. (ALRN) Stock Research Links